Role of anandamide transporter in regulating calcitonin gene-related peptide production and blood pressure in hypertension

Journal of Hypertension

Volumn 27, Issue 6, 2009, Pages 1224-1232

  Li, Dai ^a   Chen, Ben Mei ^b   Peng, Jun ^a,c   Zhang, Yi Shuai ^a   Li, Xiao Hui ^a   Yuan, Qiong ^a   Hu, Chang Ping ^a   Deng, Han Wu ^a   Li, Yuan Jian ^a,c  

^a Institute of Clinical Pharmacology   (China)

^b Central South University   (China)

^c CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Anandamide; Anandamide transporter; Asymmetric dimethylarginine; Calcitonin gene related peptide; Hypertension; Vanilloid receptor subtype 1

Indexed keywords

ANANDAMIDE; CALCITONIN GENE RELATED PEPTIDE; MESSENGER RNA; N (4 HYDROXYPHENYL)ARACHIDONAMIDE; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE;

ADULT; AGED; AMINO ACID BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL ARTICLE; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; GENE EXPRESSION; HUMAN; HUMAN CELL; MALE; NONHUMAN; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; RAT; RENOVASCULAR HYPERTENSION; SPINAL GANGLION; UPREGULATION;

EID: 67649647647     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e328329bbd7     Document Type: Article

References (40)

1. Bell D, McDermott BJ. Calcitonin gene-related peptide in the cardiovascular system: characterization of receptor populations and their (patho)physiological significance. Pharmacol Rev 1 996; 48:253-288.
2. Vaishnava P, Wang DH. Capsaicin sensitive-sensory nerves and blood pressure regulation. Curr Med Chem Cardiovasc Hematol Agents 2003; 1:177-188.
3. Li D, Peng J, Xin HY, Luo D, Zhang YS, Zhou Z, et al. Calcitonin gene-related peptide-mediated antihypertensive and antiplatelet effects by rutaecarpine in spontaneously hypertensive rats. Peptides 2008; 29:1781-1788.
4. Portaluppi F, Trasforini G, Margutti A, Vergnani L, Ambrosio MR, Rossi R, et al. Circadian rhythm of calcitonin gene-related peptide in uncomplicated essential hypertension. J Hypertens 1992; 10:1227-1234.
5. Masuda A, Shimamoto K, Mori Y, Nakagawa M, Ura N, limura O. Plasma calcitonin gene-related peptide levels in patients with various hypertensive diseases. J Hypertens 1992; 10:1499-1504.
6. Deng PY, Ye F, Zhu HQ, Cai WJ, Deng HW, Li YJ. An increase in the synthesis and release of calcitonin gene-related peptide in two-kidney, one-clip hypertensive rats. Regul Pept 2003; 114:1 75-1 82.
7. Gangula PR, Zhao H, Supowit SC, Wimalawansa SJ, Dipette DJ, Westlund KN, et al. Increased blood pressure in alpha-calcitonin gene-related peptide/calcitonin gene knockout mice. Hypertension 2000; 35:470-475.
8. Saunders Cl, Kunde DA, Crawford A, Geraghty DP. Expression of transient receptor potential vanilloid 1 (TRPV1) and 2 (TRPV2) in human peripheral blood. Mol Immunol 2007; 44:1429-1435.
9. Oh-hashi Y, Shindo T, Kurihara Y, Imai T, Wang Y, Morita H, et al. Elevated sympathetic nervous activity in mice deficient in alphaCGRP. Circ Res 2001; 89:983-990.
10. De Petrocellis L, Harrison S, Bisogno T, Tognetto M, Brandi I, Smith GD, et al. The vanilloid receptor (VRI)-mediated effects of anandamide are potently enhanced by the cAMP-dependent protein kinase. J Neurochem 2001; 77:1660-1663.
11. De Petrocellis L, Bisogno T, Davis JB, Pertwee RG, Di Marzo V. Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin-like activity. FEBS Lett 2000; 483:52-56.
12. Wang Y, Kaminski NE, Wang DH. VR1 -mediated depressor effects during high-salt intake: role of anandamide. Hypertension 2005; 46:986-991.
13. Ligresti A, Morera E, Van Der Stelt M, Monory K, Lutz B, Ortar G, Di Marzo V. Further evidence for the existence of a specific process for the membrane transport of anandamide. Biochem J 2004; 380:265-272.
14. Maccarrone M, Bari M, Lorenzon T, Bisogno T, Di Marzo V, Finazzi-Agro A. Anandamide uptake by human endothelial cells and its regulation by nitric oxide. J Biol Chem 2000; 275:13484-13492.
15. Maccarrone M, Fiori A, Bari M, Granata F, Gasperi V, De Stefano ME, et al. Regulation by cannabinoid receptors of anandamide transport across the blood-brain barrier and through other endothelial cells. Thromb Haemost 2006; 95:117-127.
16. Matsuoka H, Itoh S, Kimoto M, Kohno K, Tamai O, Wada Y, et al. Asymmetrical dimethylarginine, an endogenous nitric oxide synthase inhibitor, in experimental hypertension. Hypertension 1997; 29:242-247.
17. Perticone F, Sciacqua A, Maio R, Perticone M, Maas R, Boger RH, et al. Asymmetric dimethylarginine, L-arginine, and endothelial dysfunction in essential hypertension. J Am Coll Cardiol 2005; 46:51 8-523.
18. Closs El, Basha FZ, Habermeier A, Forstermann U. Interference of L-arginine analogues with L-arginine transport mediated by the y+ carrier hCAT-2B. Nitric Oxide 1997; 1:65-73.
19. Okubo K, Hayashi K, Wakino S, Matsuda H, Kubota E, Honda M, et al. Role of asymmetrical dimethylarginine in renal microvascular endothelial dysfunction in chronic renal failure with hypertension. Hypertens Res 2005; 28:181-189.
20. Deng PY, Yu J, Ye F, Li D, Luo D, Cai WJ, et al. Interactions of sympathetic nerves with capsaicin-sensitive sensory nerves: neurogenic mechanisms for phenol-induced hypertension in the rat. J Hypertens 2005; 23:603-609.
21. Fikri Y, Nyabenda J, Denis M, Pastoret PP. Purification and characterisation of bovine WC1 + gammadelta T lymphocytes from peripheral blood. Vet Res 2000; 31:229-239.
22. Deutsch DG, Glaser ST, Howell JM, Kunz JS, Puffenbarger RA, Hillard CJ, Abumrad N. The cellular uptake of anandamide is coupled to its breakdown by fatty-acid amide hydrolase. J Biol Chem 2001; 276:6967-6973.
23. Wang Y, Kaminski NE, Wang DH. Endocannabinoid regulates blood pressure via activation of the transient receptor potential vanilloid type 1 in Wistar rats fed a high-salt diet. J Pharmacol Exp Ther 2007; 321:763-769.
24. Li D, Xia K, Li NS, Luo D, Wang S, Jiang DJ, et al. Reduction of asymmetric dimethylarginine involved in the cardioprotective effect of losartan in spontaneously hypertensive rats. Can J Physiol Pharmacol 2007; 85:783-789.
25. Wildhirt SM, Weis M, Schulze C, Conrad N, Pehlivanli S, Rieder G, et al. Expression of endomyocardial nitric oxide synthase and coronary endothelial function in human cardiac allografts. Circulation 2001; 104:1336-343.
26. Banerjee S, Evanson J, Harris E, Lowe SL, Thomasson KA, Porter JE. Identification of specific calcitonin-like receptor residues important for calcitonin gene-related peptide high affinity binding. BMC Pharmacol 2006; 6:9.
27. Li J, Wang DH. Development of angiotensin ll-induced hypertension: role of CGRP and its receptor. J Hypertens 2005; 23:113-11 8.
28. Trang T, Ma W, Chabot JG, Quirion R, Jhamandas K. Spinal modulation of calcitonin gene-related peptide by endocannabinoids in the development of opioid physical dependence. Pain 2006; 126:256-271.
29. Wang H, Xing L, Li W, Hou L, Guo J, Wang X. Production and secretion of calcitonin gene-related peptide from human lymphocytes. J Neuroimmunol 2002; 130:155-162.
30. Luo D, Zhang YW, Peng WJ, Peng J, Chen QQ, Li D, et al. Transient receptor potential vanilloid 1-mediated expression and secretion of endothelial cell-derived calcitonin gene-related peptide. Regul Pept 2008; 150:66-72.
31. Yallampalli C, Wimalawansa SJ. Calcitonin gene-related peptide (CGRP) is a mediator of vascular adaptations during hypertension in pregnancy. Trends Endocrinol Metab 1 998; 9:113-11 7.
32. Burg M, Zahm DS, Knuepfer MM. Intrathecal capsaicin enhances one-kidney renal wrap hypertension in the rat. J Auton Nerv Syst 1 994; 50:189-199.
33. Supowit SC, Zhao H, Wang DH, DiPette DJ. Omapatrilat in subtotal nephrectomy-salt hypertension: role of calcitonin gene-related peptide. Hypertension 2001; 38:697-700.
34. Supowit SC, Zhao H, Hallman DM, DiPette DJ. Calcitonin gene-related peptide is a depressor of deoxycorticosterone-salt hypertension in the rat. Hypertension 1997; 29:945-950.
35. Schifter S, Krusell LR, Sehested J. Normal serum levels of calcitonin gene-related peptide (CGRP) in mild to moderate essential hypertension. Am J Hypertens 1 991; 4:565-569.
36. Shi XY, Yang Y, Zhao YT. Plasma calcitonin gene-related peptide (CGRP) level in patients with essential hypertension. Zhonghua Nei Ke Za Zhi 1990; 29:616-618; 639.
37. Tominaga M, Numazaki M, lida T, Moriyama T, Togashi K, Higashi T, et al. Regulation mechanisms of vanilloid receptors. Novartis Found Symp 2004; 261:4-12; discussion 12-18, 47-54.
38. Despres JP. The endocannabinoid system: a new target for the regulation of energy balance and metabolism. Crit Pathw Cardiol 2007; 6:46-50.
39. Wheal AJ, Bennett T, Randall MD, Gardiner SM. Cardiovascular effects of cannabinoids in conscious spontaneously hypertensive rats. Br J Pharmacol 2007; 152:717-724.
40. Sun MW, Zhong MF, Gu J, Qian FL, Gu JZ, Chen H. Effects of different levels of exercise volume on endothelium-dependent vasodilation: roles of nitric oxide synthase and heme oxygenase. Hypertens Res 2008; 31:805-816.